Inocras
San Diego
About Inocras
Inocras provides AI-driven genomic analysis focused on cancer and rare diseases. The company offers whole genome sequencing products, including CancerVision, RareVision, and MRDVision, alongside research services for pharmaceutical and biotechnology organizations through its CAP/CLIA-certified laboratory. Inocras employs a proprietary bioinformatics pipeline to process genomic data, supporting insights for both clinical and research applications. The company integrates sequencing and computational analysis to enable precision health approaches based on individual genomic information.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $52.7M
- Last round: Series Unknown (Dec 2024)
- Website: inocras.com
- Phone: +1 858 665 2120
Industries & Categories
Analytics, Artificial Intelligence (AI), Biotechnology, Genetics, Medical
Social Profiles
Canonical: https://fsome.com/organization/inocras-75754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.